Cargando…
Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy
Diabetic nephropathy (DN) is a common microvascular complication of diabetic patients, along with hypertension, hyperlipemia, proteinuria, edema, and other clinical manifestations. Astragalus membranaceus (AM) is a traditional Chinese medicine and has shown significant clinical efficacy against DN....
Autores principales: | Dai, Yaji, Guo, Mingfei, Jiang, Lei, Gao, Jiarong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812605/ https://www.ncbi.nlm.nih.gov/pubmed/35119030 http://dx.doi.org/10.1097/MD.0000000000028747 |
Ejemplares similares
-
Astragalus membranaceus formula for moderate-high risk idiopathic membranous nephropathy: A meta-analysis
por: Wang, Dan, et al.
Publicado: (2023) -
Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology
por: Guo, Ming-Fei, et al.
Publicado: (2020) -
Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway
por: Guo, Mingfei, et al.
Publicado: (2023) -
Identification of miRNAs and Their Response to Cold Stress in Astragalus Membranaceus
por: Abla, Merhaba, et al.
Publicado: (2019) -
Identification of key miRNAs and their targets in peripheral blood mononuclear cells of IgA nephropathy using bioinformatics analysis
por: Liu, Ling, et al.
Publicado: (2021)